Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Ozempic could also help fight dementia but ... such as Ozempic and Wegovy could have a host of other potential benefits beyond treating obesity, including a reduction in drug ...

There is currently no known cure for dementia, as Xu notes. But up to half of all dementia cases might be preventable, and scientists have identified over a dozen modifiable risk factors that ...

The study, published in the Lancet’s eClinicalMedicine journal on Thursday, explored more than 100 million medical records of U.S. patients to see if Ozempic increased the risk of several ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia.

Semaglutides like Ozempic might be the answer—and now, there’s a growing body of research which suggests the medication could also reduce your risk of developing Alzheimer’s disease and dementia.

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? While a medicine that reverses the clock would be a mi… ...

A new study published in the Journal of Alzheimer’s Disease has found that the active ingredient in popular drugs like Ozempic and Wegovy may lower the risk of developing dementia. NBC News ...

WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ingredient in Ozempic and Wegovy – could “significantlyR… ...